EFR3A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.41579999999963E-05 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.629100E-04 |
Normal-vs-Stage2 |
1.245610E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
7.258100E-02 |
Stage1-vs-Stage2 |
3.673000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.599400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.566200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.204600E-04 |
Normal-vs-AfricanAmerican |
2.721600E-01 |
Normal-vs-Asian |
1.428390E-01 |
Caucasian-vs-AfricanAmerican |
1.937190E-01 |
Caucasian-vs-Asian |
6.407600E-01 |
AfricanAmerican-vs-Asian |
4.807200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.260900E-03 |
Normal-vs-Female |
9.429600E-04 |
Male-vs-Female |
5.349600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.016760E-01 |
Normal-vs-Extreme_Weight |
4.142400E-03 |
Normal-vs-Obese |
1.161790E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.176800E-01 |
Normal_Weight-vs-Obese |
6.085200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.930400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.220300E-03 |
Normal-vs-Age(41-60Yrs) |
1.513530E-02 |
Normal-vs-Age(61-80Yrs) |
1.141580E-03 |
Normal-vs-Age(81-100Yrs) |
3.080500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.696200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.834000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.253400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.463800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.007000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.717800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.693600E-01 |
Normal-vs-Grade 3 |
8.677200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.311400E-01 |
Grade 2-vs-Grade 4 |
9.693600E-01 |
Grade 3-vs-Grade 4 |
8.677200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.408400E-04 |
Normal-vs-N1 |
5.846400E-02 |
N0-vs-N1 |
3.788200E-01 |
|
|